Document
falsefalse--12-31--12-31Q2Q2201820182018-06-302018-06-3010-Q10-Q00015745400001583994182054612YesYesLarge Accelerated FilerNon-accelerated FilerPhysicians Realty TrustPhysicians Realty L.P.P1Y16003130.015000000001814400511820273091814400511820273090.00850.0140.010.01550.0120.0180.00900.01450.01550.02250.012850000000750000001500000003500000004000000002500000000.04240.04740.04090.04030.03950.0430.0287181440051182027309181440051182027309006000005364632539223453646325392234800000P3YP2YP3YP1Y 0001574540 2018-01-01 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember 2018-01-01 2018-06-30 0001574540 2018-07-27 0001574540 2017-12-31 0001574540 2018-06-30 0001574540 2018-04-01 2018-06-30 0001574540 2017-01-01 2017-06-30 0001574540 2017-04-01 2017-06-30 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2018-01-01 2018-06-30 0001574540 us-gaap:RetainedEarningsMember 2017-12-31 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2017-12-31 0001574540 us-gaap:ParentMember 2018-01-01 2018-06-30 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2017-12-31 0001574540 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0001574540 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-06-30 0001574540 us-gaap:RetainedEarningsMember 2018-06-30 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-01-01 2018-06-30 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2018-06-30 0001574540 us-gaap:CommonStockMember 2018-01-01 2018-06-30 0001574540 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0001574540 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2018-06-30 0001574540 doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2018-01-01 2018-06-30 0001574540 us-gaap:NoncontrollingInterestMember 2017-12-31 0001574540 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001574540 us-gaap:CommonStockMember 2018-06-30 0001574540 us-gaap:ParentMember 2017-12-31 0001574540 us-gaap:ParentMember 2018-06-30 0001574540 doc:OperatingPartnershipNoncontrollingInterestMember 2017-12-31 0001574540 us-gaap:CommonStockMember 2017-12-31 0001574540 us-gaap:NoncontrollingInterestMember 2018-06-30 0001574540 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001574540 2016-12-31 0001574540 2017-06-30 0001574540 doc:PhysiciansRealtyLPMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember 2017-04-01 2017-06-30 0001574540 doc:PhysiciansRealtyLPMember 2017-01-01 2017-06-30 0001574540 doc:PhysiciansRealtyLPMember 2018-04-01 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2018-01-01 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2018-01-01 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2018-01-01 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2018-01-01 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember doc:PartiallyOwnedPropertiesNoncontrollingInterestMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember doc:PartnersCapitalMember 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember us-gaap:LimitedPartnerMember 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:GeneralPartnerMember 2017-12-31 0001574540 doc:PhysiciansRealtyLPMember 2016-12-31 0001574540 doc:PhysiciansRealtyLPMember 2017-06-30 0001574540 doc:A2016ATMProgramMember srt:MaximumMember us-gaap:PrivatePlacementMember 2016-08-05 2016-08-05 0001574540 us-gaap:SubsequentEventMember 2018-07-27 0001574540 doc:A2016ATMProgramMember us-gaap:PrivatePlacementMember 2018-01-01 2018-06-30 0001574540 doc:A2016ATMProgramMember us-gaap:PrivatePlacementMember 2018-04-01 2018-06-30 0001574540 doc:A2016ATMProgramMember us-gaap:PrivatePlacementMember 2018-01-01 2018-03-31 0001574540 2015-03-01 0001574540 doc:MezzanineLoanReceivableMember 2018-06-30 0001574540 2015-03-01 2015-03-01 0001574540 doc:TermLoanReceivableMember 2018-06-30 0001574540 us-gaap:SeriesAPreferredStockMember 2015-02-05 2015-02-05 0001574540 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2018-06-30 0001574540 doc:HealthEastClinicSpecialtyCenterMember 2018-01-01 2018-06-30 0001574540 doc:HealthEastClinicSpecialtyCenterMember 2018-01-09 2018-01-09 0001574540 doc:RedeemableNoncontrollingInterestBuyoutsMember 2018-01-01 2018-06-30 0001574540 us-gaap:SeriesAPreferredStockMember 2015-02-05 0001574540 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2017-01-01 2017-06-30 0001574540 2018-06-21 2018-06-21 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-06-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001574540 us-gaap:BuildingAndBuildingImprovementsMember 2018-06-30 0001574540 doc:AcquiredLeaseIntangiblesMember 2018-06-30 0001574540 us-gaap:OtherAssetsMember 2018-06-30 0001574540 us-gaap:LandAndLandImprovementsMember 2018-06-30 0001574540 doc:TenantImprovementsMember 2018-06-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:DispositionsSecondQuarterTwentyEighteenMember 2017-04-01 2017-06-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:DispositionsFirstAndSecondQuarterTwentyEighteenMember 2017-01-01 2017-06-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:DispositionsSecondQuarterTwentyEighteenMember 2018-04-01 2018-06-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:DispositionsFirstAndSecondQuarterTwentyEighteenMember 2018-01-01 2018-06-30 0001574540 doc:BusinessCombinationAcquisitionPeriodOneMember 2018-03-31 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2018-06-30 0001574540 doc:BusinessCombinationAcquisitionPeriodTwoMember 2018-06-30 0001574540 doc:BusinessCombinationAcquisitionPeriodTwoMember us-gaap:LeasesAcquiredInPlaceMember 2018-06-30 0001574540 doc:BusinessCombinationAcquisitionPeriodOneMember us-gaap:AboveMarketLeasesMember 2018-03-31 0001574540 doc:BusinessCombinationAcquisitionPeriodTwoMember us-gaap:AboveMarketLeasesMember 2018-06-30 0001574540 doc:BusinessCombinationAcquisitionPeriodOneMember us-gaap:LeasesAcquiredInPlaceMember 2018-03-31 0001574540 us-gaap:AboveMarketLeasesMember 2018-06-30 0001574540 doc:BelowMarketLeasesMember 2018-06-30 0001574540 doc:BusinessCombinationAcquisitionPeriodTwoMember doc:BelowMarketLeasesMember 2018-06-30 0001574540 doc:BusinessCombinationAcquisitionPeriodOneMember doc:BelowMarketLeasesMember 2018-03-31 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:DispositionsFirstQuarterTwentyEighteenMember 2018-01-01 2018-03-31 0001574540 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2018-01-01 2018-06-30 0001574540 doc:LoanInvestmentsMember 2018-01-01 2018-06-30 0001574540 doc:HMGMedicalPlazaMember 2018-04-01 2018-06-30 0001574540 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2018-04-01 2018-06-30 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2018-01-01 2018-06-30 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2018-04-01 2018-06-30 0001574540 doc:LeaseholdInterestMember 2017-12-31 0001574540 doc:LeaseholdInterestMember 2018-06-30 0001574540 doc:AboveMarketGroundLeaseMember 2017-12-31 0001574540 us-gaap:AboveMarketLeasesMember 2017-12-31 0001574540 doc:BelowMarketLeasesMember 2017-12-31 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2017-12-31 0001574540 doc:AboveMarketGroundLeaseMember 2018-06-30 0001574540 doc:BelowMarketGroundLeaseMember 2017-12-31 0001574540 doc:BelowMarketGroundLeaseMember 2018-06-30 0001574540 doc:BelowMarketGroundLeaseMember 2018-04-01 2018-06-30 0001574540 doc:BelowMarketLeasesMember 2018-01-01 2018-06-30 0001574540 doc:BelowMarketGroundLeaseMember 2017-04-01 2017-06-30 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2017-04-01 2017-06-30 0001574540 doc:LeaseholdInterestMember 2018-01-01 2018-06-30 0001574540 us-gaap:AboveMarketLeasesMember 2017-04-01 2017-06-30 0001574540 doc:LeaseholdInterestMember 2018-04-01 2018-06-30 0001574540 doc:BelowMarketLeasesMember 2017-01-01 2017-06-30 0001574540 us-gaap:AboveMarketLeasesMember 2017-01-01 2017-06-30 0001574540 doc:LeaseholdInterestMember 2017-01-01 2017-06-30 0001574540 doc:BelowMarketLeasesMember 2018-04-01 2018-06-30 0001574540 doc:BelowMarketGroundLeaseMember 2017-01-01 2017-06-30 0001574540 us-gaap:AboveMarketLeasesMember 2018-04-01 2018-06-30 0001574540 doc:BelowMarketLeasesMember 2017-04-01 2017-06-30 0001574540 us-gaap:LeasesAcquiredInPlaceMember 2017-01-01 2017-06-30 0001574540 doc:AboveMarketGroundLeaseMember 2017-01-01 2017-06-30 0001574540 doc:LeaseholdInterestMember 2017-04-01 2017-06-30 0001574540 doc:AboveMarketGroundLeaseMember 2018-01-01 2018-06-30 0001574540 doc:AboveMarketGroundLeaseMember 2018-04-01 2018-06-30 0001574540 doc:BelowMarketGroundLeaseMember 2018-01-01 2018-06-30 0001574540 doc:AboveMarketGroundLeaseMember 2017-04-01 2017-06-30 0001574540 us-gaap:AboveMarketLeasesMember 2018-01-01 2018-06-30 0001574540 srt:MinimumMember doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember 2017-12-31 0001574540 us-gaap:SeniorNotesMember 2017-03-07 2017-03-07 0001574540 doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember 2018-06-30 0001574540 doc:CreditAgreementAmendmentMember 2016-06-10 0001574540 srt:MaximumMember doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember 2018-06-30 0001574540 doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember 2017-12-31 0001574540 us-gaap:SeniorNotesMember 2017-12-01 2017-12-01 0001574540 doc:SeriesCMember us-gaap:SeniorNotesMember 2016-01-07 0001574540 srt:MinimumMember doc:CreditAgreementAmendmentMember us-gaap:RevolvingCreditFacilityMember 2016-06-09 0001574540 doc:MortgageNotesBearingVariableInterestDueIn2018And2022Member us-gaap:MortgagesMember 2018-06-30 0001574540 doc:CreditAgreementAmendmentMember doc:TermLoanMember 2016-06-10 0001574540 doc:SeriesDMember 2016-01-07 0001574540 us-gaap:SeniorNotesMember 2016-08-11 0001574540 doc:CreditAgreementAmendmentMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 srt:MaximumMember doc:MortgageNotesBearingVariableInterestDueIn2018And2022Member us-gaap:MortgagesMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:SeriesDMember us-gaap:SeniorNotesMember 2016-01-07 0001574540 doc:MortgageNotesBearingVariableInterestDue2018Member us-gaap:MortgagesMember 2017-12-31 0001574540 srt:MaximumMember doc:CreditAgreementAmendmentMember us-gaap:RevolvingCreditFacilityMember 2016-06-10 0001574540 us-gaap:SeriesBMember us-gaap:SeniorNotesMember 2016-01-07 0001574540 doc:SeriesCMember us-gaap:SeniorNotesMember 2016-08-11 0001574540 us-gaap:SeniorNotesMember 2017-03-07 0001574540 us-gaap:LetterOfCreditMember 2018-06-30 0001574540 doc:UnsecuredTermLoanDueJune2023Member us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-06-30 0001574540 srt:MaximumMember doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember 2017-12-31 0001574540 srt:MaximumMember doc:MortgageNotesBearingVariableInterestDue2018Member us-gaap:MortgagesMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-12-31 0001574540 us-gaap:InterestRateSwapMember us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-07-07 0001574540 us-gaap:SeriesAMember us-gaap:SeniorNotesMember 2016-01-07 0001574540 srt:MinimumMember doc:MortgageNotesBearingVariableInterestDue2018Member us-gaap:MortgagesMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-12-31 0001574540 us-gaap:RevolvingCreditFacilityMember 2018-06-30 0001574540 doc:CreditAgreementAmendmentMember 2018-01-01 2018-06-30 0001574540 us-gaap:SeriesAMember us-gaap:SeniorNotesMember 2016-08-11 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RevolvingCreditFacilityMember 2018-06-30 0001574540 us-gaap:SeniorNotesMember 2017-12-01 0001574540 us-gaap:SeriesAMember 2016-08-11 0001574540 us-gaap:SeriesBMember 2016-01-07 0001574540 us-gaap:SeriesBMember 2016-08-11 0001574540 doc:TermLoanMember 2016-07-07 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 srt:MinimumMember doc:MortgageNotesBearingVariableInterestDueIn2018And2022Member us-gaap:MortgagesMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:CreditAgreementAmendmentMember doc:TermLoanMember 2016-06-10 2016-06-10 0001574540 us-gaap:SeniorNotesMember 2016-01-07 0001574540 srt:MinimumMember doc:MortgageNotesBearingFixedInterestRateDueIn201720182019202020212022and2032And2022Member us-gaap:MortgagesMember 2018-06-30 0001574540 doc:TermLoanMember 2018-06-30 0001574540 us-gaap:SeriesBMember us-gaap:SeniorNotesMember 2016-08-11 0001574540 us-gaap:SeriesAMember 2016-01-07 0001574540 doc:SeriesCMember 2016-01-07 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastAorA3Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:BaseRateLoansMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastAorA3Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:BaseRateLoansMember doc:TermLoanMember us-gaap:BaseRateMember 2018-01-01 2018-06-30 0001574540 doc:RevolvingCreditFacilityDueSeptember2020Member us-gaap:RevolvingCreditFacilityMember 2018-06-30 0001574540 us-gaap:MortgagesMember 2017-12-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueMarch2027Member us-gaap:SeniorNotesMember 2018-06-30 0001574540 doc:UnsecuredNotesBearingFixedInterestDueMarch2027Member us-gaap:SeniorNotesMember 2017-12-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2028Member us-gaap:SeniorNotesMember 2018-06-30 0001574540 doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember 2018-06-30 0001574540 doc:UnsecuredTermLoanDueJune2023Member us-gaap:UnsecuredDebtMember 2017-12-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember 2017-12-31 0001574540 doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember 2017-12-31 0001574540 doc:MortgageNotesBearingVariableInterestMember us-gaap:MortgagesMember 2017-12-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember 2018-06-30 0001574540 doc:UnsecuredTermLoanDueJune2023Member us-gaap:UnsecuredDebtMember 2018-06-30 0001574540 us-gaap:MortgagesMember 2018-06-30 0001574540 doc:RevolvingCreditFacilityDueSeptember2020Member us-gaap:RevolvingCreditFacilityMember 2017-12-31 0001574540 doc:UnsecuredNotesBearingFixedInterestDueJanuary2028Member us-gaap:SeniorNotesMember 2017-12-31 0001574540 doc:MortgageNotesBearingVariableInterestMember us-gaap:MortgagesMember 2018-06-30 0001574540 srt:MinimumMember doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember 2018-06-30 0001574540 srt:MaximumMember doc:SeniorUnsecuredNotesDueAugust2025to2027Member us-gaap:SeniorNotesMember 2018-06-30 0001574540 srt:MinimumMember doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember 2018-06-30 0001574540 doc:RevolvingCreditFacilityDueSeptember2020Member us-gaap:RevolvingCreditFacilityMember 2018-01-01 2018-06-30 0001574540 srt:MaximumMember doc:UnsecuredNotesBearingFixedInterestDueJanuary2023to2031Member us-gaap:SeniorNotesMember 2018-06-30 0001574540 doc:CreditratingatleastAorA3Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastAorA3Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBplusorBAA1Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBorBAA3Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingatleastBBBorBAA2Member doc:AdjustedLIBORRateTermLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:CreditratingbelowBBBorBAA3Member doc:AdjustedLIBORRateRevolverLoansAndLetterOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 doc:UnsecuredTermLoanDueJune2023Member us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-01-01 2018-06-30 0001574540 us-gaap:RevolvingCreditFacilityMember 2018-04-01 2018-06-30 0001574540 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001574540 us-gaap:InterestRateSwapMember us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001574540 us-gaap:InterestRateSwapMember us-gaap:UnsecuredDebtMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-06-30 0001574540 doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2017-12-31 0001574540 doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2018-01-01 2018-06-30 0001574540 doc:TrusteeAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2018-01-01 2018-06-30 0001574540 doc:ExecutiveAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2018-06-30 0001574540 doc:TrusteeAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2017-12-31 0001574540 doc:TrusteeAwardsRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2018-06-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2018-06-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2018-03-01 2018-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2018-06-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2018-01-01 2018-06-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2017-12-31 0001574540 doc:PerformanceBasedRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember doc:OfficersandCertainEmployeesMember 2018-03-01 2018-03-31 0001574540 doc:MarketBasedRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember doc:OfficersandCertainEmployeesMember 2018-03-01 2018-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember doc:TrusteesMember 2018-03-01 2018-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2018-04-01 2018-06-30 0001574540 doc:PerformanceBasedRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember 2018-03-01 2018-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2014-08-07 2014-08-07 0001574540 doc:PerformanceBasedRestrictedStockUnitsRSUsMember doc:EquityIncentivePlan2013PlanMember doc:TrusteesMember 2018-03-01 2018-03-31 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2017-01-01 2017-06-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2018-01-01 2018-06-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember doc:OfficersandCertainEmployeesMember 2018-03-01 2018-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember doc:OfficersandCertainEmployeesMember 2018-01-01 2018-06-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2018-03-31 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2017-01-01 2017-06-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2018-04-01 2018-06-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2014-08-07 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2013-07-24 0001574540 us-gaap:RestrictedStockUnitsRSUMember doc:EquityIncentivePlan2013PlanMember 2017-04-01 2017-06-30 0001574540 srt:MinimumMember us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember doc:OfficersandCertainEmployeesMember 2018-01-01 2018-06-30 0001574540 us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember 2017-04-01 2017-06-30 0001574540 srt:MaximumMember us-gaap:RestrictedStockMember doc:EquityIncentivePlan2013PlanMember doc:OfficersandCertainEmployeesMember 2018-01-01 2018-06-30 0001574540 us-gaap:FairValueMeasurementsNonrecurringMember 2018-06-30 0001574540 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001574540 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001574540 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001574540 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001574540 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001574540 us-gaap:InterestRateSwapMember us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001574540 us-gaap:OperatingExpenseMember doc:ParkingAirAndGroundLeasesMember 2018-01-01 2018-06-30 0001574540 us-gaap:OperatingExpenseMember doc:ParkingAirAndGroundLeasesMember 2018-04-01 2018-06-30 0001574540 us-gaap:OperatingExpenseMember doc:ParkingAirAndGroundLeasesMember 2017-04-01 2017-06-30 0001574540 doc:CHISt.AlexiusNorthDakotaMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001574540 doc:CHIKentuckyOneHealthMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001574540 doc:CHINebraskaMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001574540 doc:USOncologyMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001574540 doc:RemainingPortfolioMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001574540 us-gaap:SalesRevenueServicesNetMember 2018-01-01 2018-06-30 0001574540 doc:BaylorScottandWhiteHealthMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember doc:AllotherstatesMember 2018-01-01 2018-06-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:IN 2018-01-01 2018-06-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:TX 2018-01-01 2018-06-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:MN 2018-01-01 2018-06-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:NE 2018-01-01 2018-06-30 0001574540 us-gaap:SalesRevenueServicesNetMember us-gaap:GeographicConcentrationRiskMember stpr:GA 2018-01-01 2018-06-30 0001574540 doc:CHIPortfolioMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001574540 doc:TopfivetenantrelationshipsMember us-gaap:SalesRevenueServicesNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember 2018-04-01 2018-06-30 0001574540 us-gaap:RestrictedStockMember 2017-04-01 2017-06-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-06-30 0001574540 us-gaap:RestrictedStockMember 2018-01-01 2018-06-30 0001574540 us-gaap:RestrictedStockMember 2017-01-01 2017-06-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-06-30 0001574540 us-gaap:RestrictedStockMember 2018-04-01 2018-06-30 0001574540 us-gaap:RestrictedStockUnitsRSUMember 2017-04-01 2017-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockUnitsRSUMember 2018-04-01 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockMember 2017-04-01 2017-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockMember 2018-01-01 2018-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockMember 2017-01-01 2017-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockUnitsRSUMember 2017-04-01 2017-06-30 0001574540 doc:PhysiciansRealtyLPMember us-gaap:RestrictedStockMember 2018-04-01 2018-06-30 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:SeventeenHealthcarePropertiesDisposedOfIn2018Member us-gaap:SubsequentEventMember 2018-07-27 2018-07-27 0001574540 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember doc:SeventeenHealthcarePropertiesDisposedOfIn2018Member us-gaap:SubsequentEventMember 2018-07-27 doc:instruments doc:properties iso4217:USD xbrli:shares xbrli:pure doc:disposition_group xbrli:shares doc:segment iso4217:USD doc:mezzanine_loan utreg:Rate doc:states doc:healthcareproperty doc:buildings doc:land doc:portfolio utreg:sqft
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
 
FORM 10-Q
 
 

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended June 30, 2018
 
or
 
☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from             to
 
Commission file number: 001-36007 (Physicians Realty Trust)
Commission file number: 333-205034-01 (Physicians Realty L.P.)
 
 
 
PHYSICIANS REALTY TRUST
PHYSICIANS REALTY L.P.
(Exact Name of Registrant as Specified in its Charter)
 
 
Maryland (Physicians Realty Trust)
Delaware (Physicians Realty L.P.)
(State of Organization)
 
46-2519850
80-0941870
(IRS Employer Identification No.)
 
 
 
309 N. Water Street,
Suite 500
Milwaukee, Wisconsin
(Address of Principal Executive Offices)
 
53202
(Zip Code)
 
(414) 367-5600
(Registrant’s Telephone Number, Including Area Code) 
 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Physicians Realty Trust        Yes ý No o            Physicians Realty L.P.        Yes ý No o    

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). 
Physicians Realty Trust        Yes ý No o            Physicians Realty L.P.        Yes ý No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Physicians Realty Trust
Large accelerated filer ý     Accelerated filer o Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company o Emerging growth company o

Physicians Realty L.P.
Large accelerated filer o     Accelerated filer o Non-accelerated filer ý (Do not check if a smaller reporting company) Smaller reporting company o Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Physicians Realty Trust      o Physicians Realty L.P. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). 
Physicians Realty Trust        Yes o No ý         Physicians Realty L.P.        Yes o No ý

The number of Physicians Realty Trust’s common shares outstanding as of July 27, 2018 was 182,054,612.
 



EXPLANATORY NOTE

This Quarterly Report on Form 10-Q combines the Quarterly Reports on Form 10-Q for the quarter ended June 30, 2018 of Physicians Realty Trust (the “Trust”), a Maryland real estate investment trust, and Physicians Realty L.P. (the “Operating Partnership”), a Delaware limited partnership. Unless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” and the “Company,” refer to the Trust, together with its consolidated subsidiaries, including the Operating Partnership. References to the “Operating Partnership” mean collectively the Operating Partnership, together with its consolidated subsidiaries. In this report, all references to “common shares” refer to the common shares of the Trust and references to “our shareholders” refer to shareholders of the common shares of the Trust, the term “OP Units” refers to partnership interests of the Operating Partnership and the term “Series A Preferred Units” refers to Series A Participating Redeemable Preferred Units of the Operating Partnership.

The Trust is a self-managed real estate investment trust (“REIT”) formed primarily to acquire, selectively develop, own, and manage healthcare properties that are leased to physicians, hospitals, and healthcare delivery systems. The Trust operates in an umbrella partnership REIT structure (“UPREIT”) in which the Operating Partnership and its subsidiaries hold substantially all of the assets. The Trust’s operations are conducted through the Operating Partnership and wholly-owned and majority-owned subsidiaries of the Operating Partnership. The Trust, as the general partner of the Operating Partnership, controls the Operating Partnership and consolidates the assets, liabilities, and results of operations of the Operating Partnership.

The Trust conducts substantially all of its operations through the Operating Partnership. As of June 30, 2018, the Trust held a 97.1% interest in the Operating Partnership and owns no Series A Preferred Units. Apart from this ownership interest, the Trust has no independent operations.

Noncontrolling interests in the Operating Partnership, shareholders’ equity of the Trust and partners’ capital of the Operating Partnership are the primary areas of difference between the consolidated financial statements of the Trust and those of the Operating Partnership. OP Units not owned by the Trust are accounted for as limited partners’ capital in the Operating Partnership’s consolidated financial statements and as noncontrolling interests in the Trust’s consolidated financial statements. The differences between the Trust’s shareholders’ equity and the Operating Partnership’s partners’ capital are due to the differences in the equity issued by the Trust and the Operating Partnership, respectively.

The Company believes combining the Quarterly Reports of the Trust and the Operating Partnership, including the notes to the consolidated financial statements, into this single report results in the following benefits:

a combined report enhances investors’ understanding of the Trust and the Operating Partnership by enabling investors to view the business as a whole in the same manner as management views and operates the business;
a combined report eliminates duplicative disclosure and provides a more streamlined and readable presentation, as a substantial portion of the Company’s disclosure applies to both the Trust and the Operating Partnership; and
a combined report creates time and cost efficiencies through the preparation of one combined report instead of two separate reports.

To help investors understand the significant differences between the Trust and the Operating Partnership, this report presents the following separate sections for each of the Trust and the Operating Partnership:

the consolidated financial statements in Part I, Item 1 of this report;
certain accompanying notes to the consolidated financial statements, including Note 3 (Acquisitions and Dispositions) and Note 14 (Earnings Per Share and Earnings Per Unit);
controls and procedures in Part I, Item 4 of this report; and
the certifications of the Chief Executive Officer and the Chief Financial Officer included as Exhibits 31 and 32 to this report.



Table of Contents

PHYSICIANS REALTY TRUST AND PHYSICIANS REALTY L.P.
 
Quarterly Report on Form 10-Q
for the Quarter Ended June 30, 2018
 
Table of Contents
 
 

 
 
Page Number
 
 
 
 
 
 
 
 
Financial Statements of Physicians Realty Trust
 
 
 
 
 
 
 
 
 
Financial Statements of Physicians Realty L.P.
 
 
 
 
 
 
 
 
 
Notes for Physicians Realty Trust and Physicians Realty L.P.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
 
This Quarterly Report on Form 10-Q contains forward-looking statements made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts may be forward-looking statements within the meaning of the federal securities laws. In particular, statements pertaining to our capital resources, property performance and results of operations contain forward-looking statements. Likewise, all of our statements regarding anticipated growth in our funds from operations and anticipated market conditions, demographics and results of operations are forward-looking statements. You can identify forward-looking statements by the use of forward-looking terminology such as “believe,” “expect,” “outlook,” “continue,” “project,” “may,” “will,” “should,” “seek,” “approximately,” “intend,” “plan,” “pro forma,” “estimate” or “anticipate” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans, expectations or intentions.
 
These forward-looking statements reflect the views of our management regarding current expectations and projections about future events and are based on currently available information. These forward-looking statements are not guarantees of future performance and involve numerous risks and uncertainties and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data or methods which may be incorrect or imprecise and we may not be able to realize them. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements:
 
general economic conditions;

adverse economic or real estate developments, either nationally or in the markets where our properties are located;

our failure to generate sufficient cash flows to service our outstanding indebtedness, or our ability to pay down or refinance our indebtedness;

fluctuations in interest rates and increased operating costs;

the availability, terms and deployment of debt and equity capital, including our unsecured revolving credit facility;

our ability to make distributions on our common shares;

general volatility of the market price of our common shares;

our increased vulnerability economically due to the concentration of our investments in healthcare properties;

our geographic concentration in Texas causes us to be particularly exposed to downturns in the Texas economy or other changes in Texas market conditions;

changes in our business or strategy;

our dependence upon key personnel whose continued service is not guaranteed;

our ability to identify, hire and retain highly qualified personnel in the future;

the degree and nature of our competition;

changes in governmental regulations or interpretations thereof, such as real estate and zoning laws and increases in real property tax rates, taxation of REITs, and similar matters;

defaults on or non-renewal of leases by tenants;

decreased rental rates or increased vacancy rates;
 
difficulties in identifying healthcare properties to acquire and completing acquisitions;

competition for investment opportunities;

1

Table of Contents

any adverse effects to the business, financial position or results of Catholic Health Initiatives’ (“CHI”), or one or more of the CHI-affiliated tenants, that impact the ability of CHI-affiliated tenants to pay us rent;

the impact of our investments in joint ventures we may make in the future and;

the financial condition and liquidity of, or disputes with, any joint venture and development partners with whom we may make co-investments in the future;

cybersecurity incidents could disrupt our business and result in the compromise of confidential information;

our ability to operate as a public company;

changes in accounting principles generally accepted in the United States “GAAP”;
 
lack of or insufficient amounts of insurance;
 
other factors affecting the real estate industry generally;

our failure to maintain our qualification as a REIT for U.S. federal income tax purposes;
 
limitations imposed on our business and our ability to satisfy complex rules in order for us to qualify as a REIT for U.S. federal income tax purposes; and
 
Other factors that may materially adversely affect us, or the per share trading price of our common shares, including:
 
the number of our common shares available for future issuance or sale;
our issuance of equity securities or the perception that such issuance might occur;
future debt;
failure of securities analysts to publish research or reports about us or our industry; and
securities analysts’ downgrade of our common shares or the healthcare-related real estate sector.

While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. We disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events, or other changes after the date of this report, except as required by applicable law. You should not place undue reliance on any forward-looking statements that are based on information currently available to us or the third parties making the forward-looking statements. For a further discussion of these and other factors that could impact our future results, performance or transactions, see Part II, Item 1A (Risk Factors) of this report and, Part I, Item 1A (Risk Factors) of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 (the “2017 Annual Report”), and Part II, Item 1A (Risk Factors) of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2018 (the “First Quarterly Report”).

2

Table of Contents

PART I.                         Financial Information
Item 1.                             Financial Statements
Physicians Realty Trust
Consolidated Balance Sheets
(In thousands, except share and per share data)
 
June 30,
2018
 
December 31,
2017
 
(unaudited)
 
 
ASSETS
 

 
 

Investment properties:
 

 
 

Land and improvements
$
201,620

 
$
217,695

Building and improvements
3,546,101

 
3,568,858

Tenant improvements
28,091

 
23,056

Acquired lease intangibles
446,127

 
458,713

 
4,221,939


4,268,322

Accumulated depreciation
(339,003
)
 
(300,458
)
Net real estate property
3,882,936


3,967,864

Real estate held for sale
111,411

 

Real estate loans receivable
68,151

 
76,195

Investments in unconsolidated entities
1,329

 
1,329

Net real estate investments
4,063,827


4,045,388

Cash and cash equivalents
9,226

 
2,727

Tenant receivables, net
5,439

 
9,966

Other assets
139,773

 
106,302

Total assets
$
4,218,265


$
4,164,383

LIABILITIES AND EQUITY
 

 
 

Liabilities:
 

 
 

Credit facility
$
459,262

 
$
324,394

Notes payable
966,586

 
966,603

Mortgage debt
139,748

 
186,471

Accounts payable
5,012

 
11,023

Dividends and distributions payable
43,357

 
43,804

Accrued expenses and other liabilities
66,115

 
56,405

Acquired lease intangibles, net
14,881

 
15,702

Total liabilities
1,694,961


1,604,402

 
 
 
 
Redeemable noncontrolling interest - Series A Preferred Units (2018) and partially owned properties
23,879

 
12,347

 
 
 
 
Equity:
 

 
 

Common shares, $0.01 par value, 500,000,000 common shares authorized, 182,027,309 and 181,440,051 common shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively
1,820

 
1,814

Additional paid-in capital
2,781,867

 
2,772,823

Accumulated deficit
(376,170
)
 
(315,417
)
Accumulated other comprehensive income
19,571

 
13,952

Total shareholders’ equity
2,427,088


2,473,172

Noncontrolling interests:
 

 
 

Operating Partnership
71,712

 
73,844

Partially owned properties
625

 
618

Total noncontrolling interests
72,337


74,462

Total equity
2,499,425


2,547,634

Total liabilities and equity
$
4,218,265


$
4,164,383

The accompanying notes are an integral part of these consolidated financial statements.

3

Table of Contents

Physicians Realty Trust
Consolidated Statements of Income
(In thousands, except share and per share data) (Unaudited)
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
Revenues:
 

 
 

 
 

 
 

Rental revenues
$
80,392

 
$
58,015

 
$
159,279

 
$
117,107

Expense recoveries
24,288

 
16,108

 
48,596

 
32,462

Interest income on real estate loans and other
2,309

 
2,476

 
4,337

 
3,696

Total revenues
106,989


76,599


212,212


153,265

Expenses:
 

 
 

 
 

 
 

Interest expense
17,154

 
11,472

 
33,648

 
21,287

General and administrative
7,104

 
6,249

 
15,563

 
10,985

Operating expenses
30,341

 
20,519

 
60,800

 
42,608

Depreciation and amortization
37,725

 
28,123

 
76,301

 
56,056

Acquisition expenses

 
5,242

 

 
10,647

Total expenses
92,324


71,605


186,312


141,583

Income before equity in income of unconsolidated entities and (loss) gain on sale of investment properties:
14,665

 
4,994

 
25,900

 
11,682

Equity in income of unconsolidated entities
29

 
29

 
57

 
57

(Loss) gain on sale of investment properties
(2,632
)
 
5,308

 
(2,563
)
 
5,308

Net income
12,062


10,331


23,394


17,047

Net income attributable to noncontrolling interests:
 

 
 

 
 

 
 

Operating Partnership
(331
)
 
(314
)
 
(644
)
 
(461
)
Partially owned properties (1)
(144
)
 
(159
)
 
(255
)
 
(326
)
Net income attributable to controlling interests
11,587


9,858


22,495


16,260

Preferred distributions
(284
)
 
(188
)
 
(771
)
 
(399
)
Net income attributable to common shareholders
$
11,303


$
9,670


$
21,724


$
15,861

Net income per share:
 

 
 

 
 

 
 

Basic
$
0.06

 
$
0.06

 
$
0.12

 
$
0.11

Diluted
$
0.06

 
$
0.06

 
$
0.12

 
$
0.11

Weighted average common shares:
 

 
 

 
 

 
 

Basic
182,002,062

 
155,366,080

 
181,906,348

 
147,221,602

Diluted
187,431,132

 
161,012,360

 
187,387,211

 
151,912,432

 
 
 
 
 
 
 
 
Dividends and distributions declared per common share and OP Unit
$
0.230

 
$
0.230

 
$
0.460

 
$
0.455

(1)
Includes amounts attributable to redeemable noncontrolling interests.

The accompanying notes are an integral part of these consolidated financial statements.

4

Table of Contents

Physicians Realty Trust
Consolidated Statements of Comprehensive Income
(In thousands) (Unaudited)
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
Net income
$
12,062

 
$
10,331

 
$
23,394

 
$
17,047

Other comprehensive income:
 
 
 
 
 
 
 
Change in fair value of interest rate swap agreements
1,321

 
(2,367
)
 
5,619

 
(780
)
Total other comprehensive income
1,321

 
(2,367
)
 
5,619

 
(780
)
Comprehensive income
13,383

 
7,964

 
29,013

 
16,267

Comprehensive income attributable to noncontrolling interests - Operating Partnership
(367
)
 
(234
)
 
(805
)
 
(435
)
Comprehensive income attributable to noncontrolling interests - partially owned properties
(144
)
 
(159
)
 
(255
)
 
(326
)
Comprehensive income attributable to common shareholders
$
12,872

 
$
7,571

 
$
27,953

 
$
15,506


The accompanying notes are an integral part of these consolidated financial statements.

5

Table of Contents

Physicians Realty Trust
Consolidated Statement of Equity
(In thousands) (Unaudited)

 
Par
Value
 
Additional
Paid in
Capital
 
Accumulated
Deficit
 
Accumulated Other Comprehensive Income
 
Total
Shareholders’ 
Equity
 
Operating
Partnership
Noncontrolling
Interest
 
Partially
Owned
Properties 
Noncontrolling
Interest
 
Total
Noncontrolling
Interests
 
Total
Equity
Balance at January 1, 2018
$
1,814

 
$
2,772,823

 
$
(315,417
)
 
$
13,952

 
$
2,473,172

 
$
73,844

 
$
618

 
$
74,462

 
$
2,547,634

Net proceeds from sale of common shares
3

 
5,967

 

 

 
5,970

 

 

 

 
5,970

Restricted share award grants, net
2

 
2,858

 
84

 

 
2,944

 

 

 

 
2,944

Purchase of OP Units

 

 

 

 

 
(303
)
 

 
(303
)
 
(303
)
Conversion of OP Units
1

 
942

 

 

 
943

 
(943
)
 

 
(943
)
 

Dividends/distributions declared

 

 
(83,837
)
 

 
(83,837
)
 
(2,408
)
 

 
(2,408
)
 
(86,245
)
Preferred distributions

 

 
(771
)
 

 
(771
)
 

 

 

 
(771
)
Distributions

 

 

 

 

 

 
(86
)
 
(86
)
 
(86
)
Change in market value of Redeemable Noncontrolling Interest

 
155

 
1,276

 

 
1,431

 

 

 

 
1,431

Change in fair value of interest rate swap agreements

 

 

 
5,619

 
5,619

 

 

 

 
5,619

Net income

 

 
22,495

 

 
22,495

 
644

 
93

 
737

 
23,232

Adjustment for Noncontrolling Interests ownership in Operating Partnership

 
(878
)
 

 

 
(878
)
 
878

 

 
878

 

Balance at June 30, 2018
$
1,820


$
2,781,867


$
(376,170
)

$
19,571

 
$
2,427,088


$
71,712


$
625


$
72,337


$
2,499,425

 
The accompanying notes are an integral part of these consolidated financial statements.



6

Table of Contents

Physicians Realty Trust
Consolidated Statements of Cash Flows
(In thousands) (Unaudited)
 
Six Months Ended
June 30,
 
2018
 
2017
Cash Flows from Operating Activities:
 

 
 

Net income
$
23,394

 
$
17,047

Adjustments to reconcile net income to net cash provided by operating activities
 
 
 

Depreciation and amortization
76,301

 
56,056

Amortization of deferred financing costs
1,214

 
1,128

Amortization of lease inducements and above/below-market lease intangibles
2,530

 
2,550

Straight-line rental revenue/expense
(12,600
)
 
(6,605
)
Amortization of discount on unsecured senior notes
285

 
98

Amortization of above market assumed debt
(31
)
 
(147
)
Loss (gain) on sale of investment properties
2,563

 
(5,308
)
Equity in income of unconsolidated entities
(57
)
 
(57
)
Distributions from unconsolidated entities
56

 
83

Change in fair value of derivative
(8
)
 
169

Provision for bad debts
(81
)
 
(840
)
Non-cash share compensation
4,619

 
3,238

Net change in fair value of contingent consideration
(50
)
 
(70
)
Change in operating assets and liabilities:
 

 
 

Tenant receivables
4,186

 
2,958

Other assets
502

 
3,293

Accounts payable
(6,011
)
 
648

Accrued expenses and other liabilities
5,501

 
14,567

Net cash provided by operating activities
102,313


88,808

Cash Flows from Investing Activities:
 

 
 

Proceeds on sales of investment properties
93,187

 
18,150

Acquisition of investment properties, net
(157,322
)
 
(756,862
)
Escrowed cash - acquisition deposits/earnest deposits
(2,220
)
 
(19,577
)
Capital expenditures on investment properties
(18,735
)
 
(8,343
)
Issuance of real estate loans receivable
(2,000
)
 
(8,594
)
Repayment of real estate loan receivable
10,271

 
1,507

Issuance of note receivable
(20,385
)
 

Repayment of note receivable

 
16,423

Leasing commissions
(2,062
)
 
(1,209
)
Lease inducements
(73
)
 
(2,063
)
Net cash used in investing activities
(99,339
)

(760,568
)
Cash Flows from Financing Activities:
 

 
 

Net proceeds from sale of common shares
5,970

 
383,676

Proceeds from credit facility borrowings
277,000

 
488,000

Payment on credit facility borrowings
(143,000
)
 
(529,000
)
Proceeds from issuance of mortgage debt

 
61,000

Proceeds from issuance of senior unsecured notes

 
396,108

Principal payments on mortgage debt
(46,809
)
 
(36,440
)
Debt issuance costs
(419
)
 
(1,065
)
Dividends paid - shareholders
(84,161
)
 
(65,529
)
Distributions to noncontrolling interests - Operating Partnership
(2,448
)
 
(1,917
)
Preferred distributions paid - OP Unit holder
(342
)
 
(519
)
Contributions from noncontrolling interest

 
47

Distributions to noncontrolling interests - partially owned properties
(262
)
 
(434
)
Payments of employee taxes for withheld stock-based compensation shares
(1,701
)
 
(2,431
)
Purchase of Series A Preferred Units

 
(19,961
)
Purchase of OP Units
(303
)
 
(3,757
)
Net cash provided by financing activities
3,525


667,778

Net increase (decrease) in cash and cash equivalents
6,499

 
(3,982
)
Cash and cash equivalents, beginning of period
2,727

 
15,491

Cash and cash equivalents, end of period
$
9,226


$
11,509

Supplemental disclosure of cash flow information - interest paid during the period
$
25,730

 
$
14,876

Supplemental disclosure of noncash activity - change in fair value of interest rate swap agreements
$
5,619

 
$
(780
)
Supplemental disclosure of noncash activity - assumed debt
$

 
$
26,379

Supplemental disclosure of noncash activity - issuance of OP Units (2017) and Series A Preferred Units in connection with acquisitions
$
22,651

 
$
44,978


The accompanying notes are an integral part of these consolidated financial statements.

7

Table of Contents

Physicians Realty L.P.
Consolidated Balance Sheets
(In thousands, except unit and per unit data)
 
June 30,
2018
 
December 31, 2017
 
(unaudited)
 
 
ASSETS
 

 
 

Investment properties:
 
 
 
Land and improvements
$
201,620

 
$
217,695

Building and improvements
3,546,101

 
3,568,858

Tenant improvements
28,091

 
23,056

Acquired lease intangibles
446,127

 
458,713

 
4,221,939

 
4,268,322

Accumulated depreciation
(339,003
)
 
(300,458
)
Net real estate property
3,882,936

 
3,967,864

Real estate held for sale
111,411

 

Real estate loans receivable
68,151

 
76,195

Investments in unconsolidated entities
1,329

 
1,329

Net real estate investments
4,063,827

 
4,045,388

Cash and cash equivalents
9,226

 
2,727

Tenant receivables, net
5,439

 
9,966

Other assets
139,773

 
106,302

Total assets
$
4,218,265

 
$
4,164,383

LIABILITIES AND CAPITAL
 
 
 
Liabilities:
 
 
 
Credit facility
$
459,262

 
$
324,394

Notes payable
966,586

 
966,603

Mortgage debt
139,748

 
186,471

Accounts payable
5,012

 
11,023

Distributions payable
43,357

 
43,804

Accrued expenses and other liabilities
66,115

 
56,405

Acquired lease intangibles, net
14,881

 
15,702

Total liabilities
1,694,961

 
1,604,402

 
 
 
 
Redeemable noncontrolling interest - Series A Preferred Units (2018) and partially owned properties
23,879

 
12,347

 
 
 
 
Capital:
 
 
 
Partners’ capital:
 
 
 
General partners’ capital, 182,027,309 and 181,440,051 units issued and outstanding as of June 30, 2018 and December 31, 2017, respectively
2,407,517

 
2,459,220

Limited partners’ capital, 5,392,234 and 5,364,632 units issued and outstanding as of June 30, 2018 and December 31, 2017, respectively
71,712

 
73,844

Accumulated other comprehensive income
19,571

 
13,952

Total partners’ capital
2,498,800

 
2,547,016

Noncontrolling interest - partially owned properties
625

 
618

Total capital
2,499,425

 
2,547,634

Total liabilities and capital
$
4,218,265

 
$
4,164,383


The accompanying notes are an integral part of these consolidated financial statements.


8

Table of Contents

Physicians Realty L.P.
Consolidated Statements of Income
(In thousands, except unit and per unit data) (Unaudited)
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
Revenues:
 

 
 

 
 

 
 

Rental revenues
$
80,392

 
$
58,015

 
$
159,279

 
$
117,107

Expense recoveries
24,288

 
16,108

 
48,596

 
32,462

Interest income on real estate loans and other
2,309

 
2,476

 
4,337

 
3,696

Total revenues
106,989

 
76,599

 
212,212

 
153,265

Expenses:
 
 
 
 
 
 
 
Interest expense
17,154

 
11,472

 
33,648

 
21,287

General and administrative
7,104

 
6,249

 
15,563

 
10,985

Operating expenses
30,341

 
20,519

 
60,800

 
42,608

Depreciation and amortization
37,725

 
28,123

 
76,301

 
56,056

Acquisition expenses

 
5,242

 

 
10,647

Total expenses
92,324

 
71,605

 
186,312

 
141,583

Income before equity in income of unconsolidated entities and (loss) gain on sale of investment properties:
14,665

 
4,994

 
25,900

 
11,682

Equity in income of unconsolidated entities
29

 
29

 
57

 
57

(Loss) gain on sale of investment properties
(2,632
)
 
5,308

 
(2,563
)
 
5,308

Net income
12,062

 
10,331

 
23,394

 
17,047

Net income attributable to noncontrolling interests - partially owned properties (1)
(144
)
 
(159
)
 
(255
)
 
(326
)
Net income attributable to controlling interests
11,918

 
10,172

 
23,139

 
16,721

Preferred distributions
(284
)
 
(188
)
 
(771
)
 
(399
)
Net income attributable to common unitholders
$
11,634

 
$
9,984

 
$
22,368

 
$
16,322

Net income per common unit:
 
 
 
 
 
 
 
Basic
$
0.06

 
$
0.06

 
$
0.12

 
$
0.11

Diluted
$
0.06

 
$
0.06

 
$
0.12

 
$
0.11

Weighted average common units:
 
 
 
 
 
 
 
Basic
187,394,619

 
160,765,345

 
187,329,702

 
151,520,407

Diluted
187,431,132

 
161,012,360

 
187,387,211

 
151,912,432

 
 
 
 
 
 
 
 
Distributions declared per common unit
$
0.230

 
$
0.230

 
$
0.460

 
$
0.455

(1)
Includes amounts attributable to redeemable noncontrolling interests.

The accompanying notes are an integral part of these consolidated financial statements.


9

Table of Contents

Physicians Realty L.P.
Consolidated Statements of Comprehensive Income
(In thousands) (Unaudited)
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017
 
2018
 
2017
Net income
$
12,062

 
$
10,331

 
$
23,394

 
$
17,047

Other comprehensive income:
 
 
 
 
 
 
 
Change in fair value of interest rate swap agreements
1,321

 
(2,367
)
 
5,619

 
(780
)
Total other comprehensive income
1,321

 
(2,367
)
 
5,619

 
(780
)
Comprehensive income
13,383

 
7,964

 
29,013

 
16,267

Comprehensive income attributable to noncontrolling interests - partially owned properties
(144
)
 
(159
)
 
(255
)
 
(326
)
Comprehensive income attributable to common unitholders
$
13,239

 
$
7,805

 
$
28,758

 
$
15,941


The accompanying notes are an integral part of these consolidated financial statements.


10

Table of Contents

Physicians Realty L.P.
Consolidated Statement of Changes in Capital
(In thousands) (Unaudited)
 
General Partner
 
Limited Partner
 
Accumulated Other Comprehensive Income
 
Total
Partners’ Capital
 
Partially
Owned
Properties
Noncontrolling
Interest
 
Total Capital
Balance at January 1, 2018
2,459,220

 
73,844

 
13,952

 
2,547,016

 
618

 
2,547,634

Net proceeds from sale of Trust common shares and issuance of common units
5,970

 

 

 
5,970

 

 
5,970

Trust restricted share award grants, net
2,944

 

 

 
2,944

 

 
2,944

Purchase of OP Units

 
(303
)
 

 
(303
)
 

 
(303
)
Conversion of OP Units
943

 
(943
)
 

 

 

 

OP Units - distributions
(83,837
)
 
(2,408
)
 

 
(86,245
)
 

 
(86,245
)
Preferred distributions
(771
)
 

 

 
(771
)